NCT00234182View on ClinicalTrials.gov

Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

January 31, 2000

Study Completion Date

December 31, 2004

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

Interferon alpha-2b

All Listed Sponsors
lead

The University of Hong Kong

OTHER

NCT00234182 - Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC | Biotech Hunter | Biotech Hunter